AstraZeneca PLC (BVMF:A1ZN34)
79.60
-1.05 (-1.30%)
Last updated: Dec 4, 2025, 2:14 PM GMT-3
AstraZeneca Ratios and Metrics
Market cap in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,519,971 | 1,256,595 | 1,015,431 | 1,107,234 | 1,014,241 | 681,653 | Upgrade
|
| Market Cap Growth | 28.25% | 23.75% | -8.29% | 9.17% | 48.79% | 28.30% | Upgrade
|
| Enterprise Value | 1,651,743 | 1,411,241 | 1,139,326 | 1,260,280 | 1,167,385 | 778,131 | Upgrade
|
| Last Close Price | 81.52 | 66.13 | 52.00 | 55.96 | - | - | Upgrade
|
| PE Ratio | 30.34 | 28.88 | 35.14 | 63.70 | 1625.31 | 41.07 | Upgrade
|
| PS Ratio | 4.91 | 3.76 | 4.57 | 4.72 | 4.87 | 4.93 | Upgrade
|
| PB Ratio | 6.20 | 4.97 | 5.34 | 5.65 | 4.63 | 8.39 | Upgrade
|
| P/FCF Ratio | 22.53 | 20.45 | 23.29 | 24.03 | 37.36 | 34.20 | Upgrade
|
| P/OCF Ratio | 18.84 | 17.13 | 20.23 | 21.35 | 30.53 | 27.35 | Upgrade
|
| EV/Sales Ratio | 5.30 | 4.22 | 5.13 | 5.38 | 5.60 | 5.63 | Upgrade
|
| EV/EBITDA Ratio | 14.84 | 12.99 | 16.51 | 17.35 | 31.27 | 21.44 | Upgrade
|
| EV/EBIT Ratio | 19.37 | 17.65 | 24.34 | 27.05 | 72.32 | 34.29 | Upgrade
|
| EV/FCF Ratio | 24.48 | 22.96 | 26.14 | 27.35 | 43.01 | 39.04 | Upgrade
|
| Debt / Equity Ratio | 0.71 | 0.75 | 0.76 | 0.84 | 0.85 | 1.45 | Upgrade
|
| Debt / EBITDA Ratio | 1.57 | 1.70 | 2.04 | 2.23 | 4.81 | 3.15 | Upgrade
|
| Debt / FCF Ratio | 2.58 | 3.07 | 3.30 | 3.57 | 6.85 | 5.92 | Upgrade
|
| Asset Turnover | 0.53 | 0.53 | 0.46 | 0.44 | 0.44 | 0.42 | Upgrade
|
| Inventory Turnover | 1.59 | 1.80 | 1.59 | 1.26 | 1.85 | 1.45 | Upgrade
|
| Quick Ratio | 0.69 | 0.67 | 0.58 | 0.62 | 0.67 | 0.67 | Upgrade
|
| Current Ratio | 0.88 | 0.93 | 0.82 | 0.86 | 1.16 | 0.96 | Upgrade
|
| Return on Equity (ROE) | 21.67% | 17.59% | 15.64% | 8.63% | 0.42% | 20.80% | Upgrade
|
| Return on Assets (ROA) | 9.06% | 7.88% | 6.10% | 5.46% | 2.10% | 4.26% | Upgrade
|
| Return on Capital (ROIC) | 13.16% | 11.53% | 8.80% | 7.82% | 3.26% | 7.45% | Upgrade
|
| Return on Capital Employed (ROCE) | 19.80% | 17.00% | 13.70% | 12.60% | 3.50% | 9.40% | Upgrade
|
| Earnings Yield | 3.30% | 3.46% | 2.85% | 1.57% | 0.06% | 2.44% | Upgrade
|
| FCF Yield | 4.44% | 4.89% | 4.29% | 4.16% | 2.68% | 2.92% | Upgrade
|
| Dividend Yield | 1.74% | 28.99% | 27.06% | 27.39% | - | - | Upgrade
|
| Payout Ratio | 52.89% | 65.80% | 75.25% | 132.72% | 3442.86% | 111.77% | Upgrade
|
| Buyback Yield / Dilution | 0.08% | -0.06% | -0.13% | -9.32% | -8.68% | -0.92% | Upgrade
|
| Total Shareholder Return | 1.82% | 28.93% | 26.93% | 18.07% | -8.68% | -0.92% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.